SynthesisHead & neck2026
Artificial Intelligence-Driven MRI for Cervical Nodal Metastasis Detection in Oral Squamous Cell Carcinoma: A Hierarchical Meta-Analysis of Diagnostic Accuracy.
Synthesis in Head & neck, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArtificial intelligence (AI) applied to magnetic resonance imaging (MRI) may improve detection of cervical lymph node metastases in oral squamous cell carcinoma (OSCC) but is heterogeneous.
methodsA systematic review identified observational studies (from 2000) evaluating AI-based MRI in adults with histopathologically confirmed OSCC. Risk of bias was assessed with QUADAS-AI. Diagnostic performance was synthesized using a hierarchical bivariate model. Publication bias and certainty of evidence were assessed using Deeks' test and GRADE.
resultsTwelve studies were included; seven datasets (548 participants) were meta-analyzed. Pooled sensitivity was 0.72 (95% CI: 0.62-0.80) and specificity 0.79 (95% CI: 0.73-0.83), with AUC 0.82 and diagnostic odds ratio 9.42. Heterogeneity is mainly related to threshold effects. No significant publication bias was detected (p = 0.536). Evidence certainty was low.
conclusionsAI-assisted MRI shows moderate diagnostic performance. Multicenter validation is required before clinical implementation. CLINICAL RELEVANCE: AI-supported MRI may serve as an adjunctive tool to improve preoperative risk stratification of cervical lymph node metastasis in OSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.